Literature DB >> 4114679

Preclinical toxicologic evaluation of bleomycin (NSC 125 066), a new antitumor antibiotic.

G R Thompson, J R Baker, R W Fleischman, H Rosenkrantz, U H Schaeppi, D A Cooney, R D Davis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4114679     DOI： 10.1016/0041-008x(72)90283-9

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN： 0041-008X            Impact factor:   4.219


× No keyword cloud information.
  4 in total

1.  Evaluation of antitumor drug side effects in small animals.

Authors:  W T Bradner; J E Schurig; J B Huftalen; G J Doyle
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

2.  Tallysomycin S10b--a phase I trial.

Authors:  P G Sørensen; H Pedersen; H V Clausen; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

3.  Protective effect of spin-labeled 1-ethyl-1-nitrosourea against oxidative stress in liver induced by antitumor drugs and radiation.

Authors:  V Gadjeva; B Grigorov; G Nikolova; A Tolekova; A Zheleva; M Vasileva
Journal:  Biomed Res Int       Date:  2013-09-24       Impact factor: 3.411

Review 4.  Modeling DNA damage-induced pneumopathy in mice: insight from danger signaling cascades.

Authors:  Florian Wirsdörfer; Verena Jendrossek
Journal:  Radiat Oncol       Date:  2017-08-24       Impact factor: 3.481
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.